Holen Sie sich die Stockscreener-App
0.64
0.72%
0.00455
Schlusskurs vom Vortag:
$0.6354
Offen:
$0.63
24-Stunden-Volumen:
5,034
Relative Volume:
0.01
Marktkapitalisierung:
$9.56M
Einnahmen:
Nettoeinkommen (Verlust:
$-15.91M
KGV:
-0.4429
EPS:
-1.445
Netto-Cashflow:
$-15.07M
1W Leistung:
-0.21%
1M Leistung:
-47.55%
6M Leistung:
-73.99%
1J Leistung:
-84.31%
1-Tages-Spanne:
$0.63
$0.6599
1-Wochen-Bereich:
$0.591
$0.7501
52-Wochen-Spanne:
$0.591
$4.34
Lantern Pharma Inc Stock (LTRN) Company Profile
Firmenname
Lantern Pharma Inc
Sektor
Branche
Telefon
972-277-1136
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Compare LTRN vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
0.64 | 9.56M | 0 | -15.91M | -15.07M | -1.445 |
VRTX
Vertex Pharmaceuticals Inc
|
521.85 | 132.27B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
814.46 | 83.85B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
202.00 | 80.65B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
882.54 | 55.50B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.89 | 42.41B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-07 | Eingeleitet | H.C. Wainwright | Buy |
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
A reported Lantern Pharma (LTRN) stake includes 212,554 shares issuable through warrants. - Stock Titan
Form PRE 14A LANTERN PHARMA INC. For: 10 October By Investing.com - Investing.com South Africa
Form PRE 14A LANTERN PHARMA INC. For: 10 October By Investing.com - Investing.com Canada
Lantern Pharma Schedules Virtual 2026 Annual Meeting with Seven Key Proposals on December 1 - Kalkine Media
With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. - Stock Titan
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026 - Business Wire
More than half of Taiwan’s lung cancer patients never smoked. A trial site there is screening patients. - Stock Titan
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance UK
After 30 business days below Nasdaq's value minimum, Lantern Pharma (NASDAQ: LTRN) has time to comply. - Stock Titan
Lantern Pharma (NASDAQ: LTRN) Closes $4 Million Registered Direct Offering - The Globe and Mail
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - BioSpace
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com South Africa
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Canada
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Nigeria
Lantern Pharma closes $4 million stock offering - Investing.com
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com India
Lantern Pharma Raises $4.0 Million in Registered Direct; Issues Warrants, Engages Rodman & Renshaw - TradingView
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - Business Wire
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com South Africa
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Nigeria
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Canada
Lantern Pharma raises $4M in registered direct offering - Investing.com
Lantern Pharma announces up to $8M registered direct offering - TradingView
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering - Business Wire
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering - Yahoo Finance
Lantern Pharma raises $4M in registered direct offering By Investing.com - Investing.com UK
Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com India
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com UK
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com UK
A cancer drug could gain patent protection through 2042. Lantern Pharma’s LP-284 targets two blood cancers. - Stock Titan
Lantern Pharma Inc (NASDAQ: LTRN) Share Price, LTRN Stock News, LTRN Share Price & Updates - kalkine.ca
Lantern Pharma Inc (NASDAQ: LTRN) Share Price, LTRN Stock News, LTRN Share Price & Updates - Kalkine
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript - benzinga.com
Lantern Pharma Share PriceLTRN, RNS News, Articles, Quotes, & Charts (NASDAQ:LTRN) - Proactive financial news
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - guardonline.com
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - 富途牛牛
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - Yahoo Finance
Lantern Pharma (NasdaqCM:LTRN) Stock Forecast & Analyst Predictions - Simply Wall Street
Lantern Pharma Inc. (LTRN) Stock Price & News - Syfe
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum - TipRanks
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - AOL.com
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Sahm
Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Simply Wall Street
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI - GuruFocus
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lantern Pharma Inc-Aktie (LTRN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KEYSER D JEFFREY | Director |
May 12 '26 |
Buy |
2.06 |
48,544 |
100,001 |
94,303 |
6.52%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):